New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
12:31 EDTGIS, ULTA, CTB, CELG, GMCR, ARO, SBUXOn The Fly: Midday Wrap
Stocks on Wall Street traded in a narrow band on either side of the flat-line in the early going, as the news flow continues to be dominated by developments between Russia and Ukraine. Stocks opened in quiet fashion and moved to the upside early in the session. The market was unable to hold its gains, however, and reversed course following a report that indicated that consumer sentiment has fallen this month. The averages crossed back into positive territory right before noon, but the market has remained in a narrow range throughout the morning's swings. ECONOMIC EVENTS: In the U.S., producer prices fell 0.1% overall in February, versus an expected increase of 0.2%. The core reading, which excludes food and energy, fell 0.2%, versus an expected increase of 0.1%. The Reuters/University of Michigan Consumer Sentiment Survey for March unexpectedly dropped to a four-month low of 79.9. The preliminary reading for the month was expected by analysts to have come in at 81.8, which would have been a slight bump from the prior 81.6 figure. In Europe, one person reportedly died and several were injured after violent clashes in the Ukrainian city of Donetsk amid demonstrations from those opposed to Russia’s military intervention in Crimea. Also, reports indicated the Russian military conducted another military exercise near Ukraine on Thursday. COMPANY NEWS: Shares of single-serve coffee machine maker Keurig Green Mountain (GMCR) rose nearly 9% after the company agreed to new terms in its deal with coffee giant Starbucks (SBUX). Research firm Buckingham said its views Keurig's amended deal with Starbucks as a positive event for both companies. The new agreement lets Keurig pursue additional premium unlicensed brands and provides Starbucks an opportunity for better margins, said the firm... Shares of teen retailer Aeropostale (ARO) fell almost 14% after its fourth quarter results and first quarter outlook missed analysts' consensus expectations. The retailer also entered a financing deal with private equity firm Sycamore Partners for a strategic partnership and $150M in senior secured credit facilities. Aeropostale will also issue convertible preferred stock to Sycamore that gives the firm the right to acquire up to 5% of the company's common stock at an exercise price of $7.25, the closing price of the company's common stock on March 12. MAJOR MOVERS: Among the notable gainers was beauty retailer Ulta Salon (ULTA), which advanced over 7% after the company’s fourth quarter results beat estimates. Also higher following its quarterly earnings report was tire maker Cooper Tire & Rubber (CTB), which rose nearly 8%. Among the noteworthy losers was Celgene (CELG), which dropped almost 3% after the U.K.'s healthcare guidance body issued new draft guidance on the use of the company's Revlimid drug. Also lower were shares of cereal and packaged foods maker General Mills (GIS), which slid 2% after the company warned its third quarter earnings could miss expectations. INDEXES: Near midday, the Dow was up 1.15, or 0.01%, to 16,110.04, the Nasdaq was up 1.74, or 0.04%, to 4,262.16, and the S&P 500 was virtually unchanged at 1,846.36.
News For GMCR;SBUX;ARO;ULTA;CELG;CTB;GIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 19, 2014
14:40 EDTGMCRKeurig Green Mountain technical comments ahead of results
Subscribe for More Information
14:08 EDTGMCREarnings Preview: Keurig Green Mountain sees FY14 EPS $3.71-$3.78
Subscribe for More Information
13:26 EDTGMCRKeurig Green Mountain November 155 straddle priced for 8.7% move into Q4
10:47 EDTGMCRStocks with call strike movement; GME GMCR
GameStop (GME) December 55 call option implied volatility increased 4% to 55, Green Mountain (GMCR) December 185 call option implied volatility increased 3% to 54 according to IVolatility.
10:14 EDTULTAUlta Salon's Q3 traffic trends strong, says ITG Research
Subscribe for More Information
10:00 EDTCTBOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:39 EDTCELGCelgene management to meet with ISI Group
Subscribe for More Information
06:48 EDTGISGeneral Mills to remove '100% Natural' from Nature Valley products, WSJ says
Subscribe for More Information
06:16 EDTCTBCooper Tire initiated with an Outperform at FBR Capital
Subscribe for More Information
November 18, 2014
11:40 EDTAROUrban Outfitters sinks to 52-week low after Q3 profit misses consensus
Subscribe for More Information
08:07 EDTGMCRGreen Mountain Coffee volatility elevated into Q3 and outlook
Green Mountain Coffee November call option implied volatility is at 101, December is at 50, January is at 45, March is at 43; compared to its 26-week average of 42 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on November 19.
07:50 EDTGMCRKeurig Green Mountain price target raised to $168 from $134 at Canaccord
Subscribe for More Information
07:34 EDTCELGCelgene presents long-term OTEZLA data at ACR/ARHP meeting
Celgene announced that results from long-term efficacy and safety analyses of OTEZLA from the open-label phase of two PALACE phase III clinical trials were presented at the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals annual meeting in Boston. OTEZLA is the Company’s oral, selective inhibitor of phosphodiesterase 4, approved by the U.S. FDA for the treatment of adult patients with active psoriatic arthritis and for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. In PALACE 1, 84 percent of patients who completed one year of 30 mg twice daily therapy continued to receive OTEZLA at two years. Improvements in efficacy measures observed at 52 weeks were sustained through 104 weeks of treatment. At week 104, among patients receiving OTEZLA 30 mg twice daily, the ACR20 response rate was 65.3 percent. ACR50 and 70 response rates were 34.0 percent and 19.6 percent, respectively, at week 104. Similar findings were observed in PALACE 4. In this trial, nearly 84 percent of DMARD-naïve patients who completed one year of OTEZLA 30 mg twice daily monotherapy continued to receive OTEZLA at two years. At week 104, among patients treated with OTEZLA 30 mg twice daily monotherapy, an ACR20, 50 and 70 response was reached by 61.4 percent, 40.7 percent and 19.2 percent of patients, respectively. In both PALACE 1 and PALACE 4, changes in other efficacy measures—including the HAQ-DI, which assesses improvements in physical function, and swollen and tender joint counts—were also generally sustained between weeks 52 and 104 with continued OTEZLA treatment. In PALACE 4, treatment with OTEZLA in patients with pre-existing enthesitis or dactylitis, two key manifestations of psoriatic arthritis, resulted in improvements in enthesitis and dactylitis that were sustained through 104 weeks of treatment.
November 17, 2014
07:26 EDTGMCRBofA/Merrill expects in-line Q4 report from Keurig Green Mountain
Subscribe for More Information
07:16 EDTCELGMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
17:07 EDTCELGSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
09:05 EDTGMCRKeurig Green Mountain target to $185, Cold may be a disrupter, says Goldman
Subscribe for More Information
08:31 EDTGMCRGreen Mountain Coffee November volatility elevated into Q3 and outlook
Subscribe for More Information
07:14 EDTCELGAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
06:16 EDTSBUXEU says Starbucks tax deal in Netherlands may be illegal state aid, WSJ says
The European Union said the tax deal struck by Starbucks (SBUX) in the Netherlands amounts to illegal state aid, reports the Wall Street Journal. European Commission regulators said it reached a preliminary view that the tax deal violated guidelines produced by the Organization for Economic Cooperation and Development. It said the tax deal "tolerates questionable adjustments which allow Starbucks Manufacturing BV to lower the resulting corporate income tax basis in the Netherlands." The EU is also investigating tax arrangements of Apple (AAPL) in Ireland and Amazon (AMZN) and Fiat S.p.A. (FIATY) in Luxembourg. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use